Center of Biomedical Research Excellence in Matrix Biology Phase II
Center of Biomedical Research Excellence in Matrix Biology Phase II
批准号:
10640905
负责人:
JULIA THOM OXFORD
金额:
$210.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-05-31
关键词:
AddressAreaAwardBioinformaticsBiologyBiomedical EngineeringBiomedical ResearchBiometryCenters of Research ExcellenceChemistryCollaborationsCommunitiesCore FacilityDedicationsDevelopmentDevelopment PlansDisciplineDiseaseDisease ProgressionElectrical EngineeringEngineeringEnvironmentExtracellular MatrixExtramural ActivitiesFundingFutureGoalsGrantGrowthHealthHistologyIdahoImageIndividualInfrastructureInstitutionInterdisciplinary StudyInvestigationJournalsLaboratoriesManuscriptsMechanicsMentorsMicroscopyNatural regenerationNaturePeer ReviewPhasePhysicsPilot ProjectsPositioning AttributePreventionPrincipal InvestigatorProteomicsPublishingResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingRoleScienceSecureTissuesUniversitiescareer developmentcomputer sciencedisease diagnosisimprovedinstrumentationlaboratory facilitymaterials sciencemetabolomicsmultidisciplinaryprogramsrecruitrepairedsuccesstherapeutic developmenttraining opportunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract - Overall
The long-term goal of the Center of Biomedical Research Excellence (COBRE) in Matrix Biology is to
establish, enhance, and actively advance a multidisciplinary research center focusing on improving our
understanding of the role of the extracellular matrix in development, health, and disease, and contributing to
the prevention, treatment, and cure for diseases of high priority. Since the beginning of Phase I in 2014, we
have vigorously intervened limitations that hinder achieving our goals. Program accomplishments resulting
from career development and mentoring of junior investigators led to an increase in research grant awards
during Phase I. We accomplished an increase in access to and use of shared instrumentation within the
COBRE Core facilities. Most importantly, a culture shift has occurred at Boise State University. Seven
investigators received significant new funding and graduated from the COBRE mentoring program. The Pilot
Project Program contributed to investigator success and served as an onramp for two of our Research Project
Investigators working toward R01 grant submission during Phase II. A critical mass of investigators has been
established around the thematic focus of matrix biology that includes a diverse cadre from disciplines including
biology, chemistry, physics, materials science, computer science, mechanical and biomedical engineering, and
electrical engineering. The COBRE program has put Boise State in a position to make significant contributions
to solutions addressing national health concerns. New laboratories have been built and core facilities have
been established supporting proteomics and metabolomics, histology, microscopy, imaging, and
biostatistics/bioinformatics. COBRE investigators published 98 peer-reviewed manuscripts including
noteworthy articles in journals of high impact. Phase II is critically important for us to continue our upward
momentum toward our goals of research growth over the next five years. To achieve this overarching goal, four
specific aims are proposed: 1) enhance and grow upon the critical mass of investigators established around
the thematic multidisciplinary focus of matrix biology, 2) enhance biomedical research core capabilities, 3)
grow research collaborations with existing programs, and 4) enhance research training opportunities. Upon
successful completion of the proposed aims, we will have strengthened and enhanced the critical mass of
investigators with shared priorities in understanding the role of the matrix in development and disease. Shared
core facilities will be enhanced and will support the needs of more investigators as they follow a mentored
career development plan. The multidisciplinary nature that was established in Phase I will continue to grow to
include additional investigators across our institution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center of Biomedical Research
-
批准号:8625918
-
项目类别:
-
资助金额:$199.65万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research
-
批准号:9310452
-
项目类别:
-
资助金额:$198.4万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10415171
-
项目类别:
-
资助金额:$210.75万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10640906
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10844074
-
项目类别:
-
资助金额:$72.34万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10894421
-
项目类别:
-
资助金额:$72.34万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10397810
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:8653269
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10226308
-
项目类别:
-
资助金额:$83.53万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Administrative Core
-
批准号:10415172
-
项目类别:
-
资助金额:$78.31万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
SARS-CoV-2 Surveillance Studies in Southwest Idaho
-
批准号:10594358
-
项目类别:
-
资助金额:$70.1万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research
-
批准号:8898140
-
项目类别:
-
资助金额:$203.95万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Center of Biomedical Research Excellence in Matrix Biology Phase II
-
批准号:10226307
-
项目类别:
-
资助金额:$210.75万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
Role of mechanical stress in mitigating chemotherapy-associated bone loss
-
批准号:10722845
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2014
-
负责人:JULIA THOM OXFORD
-
依托单位:
MULTIPLICITY OF COL11A1 FUNCTION DURING DEVELOPMENT; STRUCTURE AND SIGNALING
-
批准号:8359680
-
项目类别:
-
资助金额:$11.15万
-
财政年份:2011
-
负责人:JULIA THOM OXFORD
-
依托单位:
MULTIPLICITY OF COL11A1 FUNCTION DURING DEVELOPMENT; STRUCTURE AND SIGNALING
-
批准号:8167434
-
项目类别:
-
资助金额:$11.27万
-
财政年份:2010
-
负责人:JULIA THOM OXFORD
-
依托单位:
SKELETAL BIOLOGY AND ARTHRITIS
-
批准号:7959941
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2009
-
负责人:JULIA THOM OXFORD
-
依托单位:
SKELETAL BIOLOGY AND ARTHRITIS
-
批准号:7720026
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2008
-
负责人:JULIA THOM OXFORD
-
依托单位:
Type XI collagen isoforms in skeletal biology
-
批准号:6462827
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2002
-
负责人:JULIA THOM OXFORD
-
依托单位:
Type XI collagen isoforms in skeletal biology
-
批准号:7100220
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2002
-
负责人:JULIA THOM OXFORD
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: